Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J F Macfarlan & Co was a pioneering Scottish pharmaceutical company founded in 1780, specializing in the extraction of opium alkaloids and the production of anesthetics. The company gained international recognition for its high-purity morphine, codeine, and chloroform, playing a critical role in the development of modern pain management and surgical anesthesia. Notably, the firm supplied chloroform to Sir James Young Simpson for his landmark use of anesthetics in medical practice. In 1962, the company merged with its long-time rival T & H Smith Ltd to form Edinburgh Pharmaceutical Industries (EPI). EPI was subsequently acquired by Glaxo in 1963, and the manufacturing legacy continues today under the name Macfarlan Smith. The company's historical contributions remain foundational to the pharmaceutical industry and the development of controlled substance manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J F Macfarlan & Co.